The insulin and insulin-like growth factor I (IGF-1) signaling pathways are characterized by close homologies in hormone structure, receptor structure, and the signaling intermediates activated as a consequence of hormone binding. However, despite these marked similarities, insulin functions primarily as a metabolic regulatory hormone and IGF-I primarily as a growth factor. The long-term goals of this project are to define the molecular mechanisms that establish specificity in the insulin and IGF-I pathways, and extent of physiologically important interactions between insulin and the IGFS. Two-hybrid cloning studie during the previous grant period identified Grb10 as a novel protein that bind to the intracellular domain of activated insulin receptors but not IGF-1 receptors. This occurs through two receptor-binding sites in Grb10, an SH2 domain and a previously uncharacterized protein interaction motif. Grb10 co-precipitates with additional proteins besides the insulin receptor.
The specific aims of this project are: (1) to investigate Grb10 function by introducing various constructs of this protein into insulin-responsive cell systems using recombinant adenovirus, (2) to identify proteins in addition to the insulin receptor that bind to Grb10 by both two-hybrid cloning and GST-Grb 10 fusion protein interaction methods, (3) to investigate the multiple isoform of Grb10 that have been identified, (4) to investigate the sites and functiona importance of Grb10 phosphorylation, and (5) to determine the structural basis for GrblO binding to the insulin receptor.

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Research Project (R01)
Project #
5R01DK043038-06
Application #
2900232
Study Section
Metabolism Study Section (MET)
Program Officer
Margolis, Ronald N
Project Start
1992-02-01
Project End
2003-03-31
Budget Start
1999-04-18
Budget End
2000-03-31
Support Year
6
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Joslin Diabetes Center
Department
Type
DUNS #
071723084
City
Boston
State
MA
Country
United States
Zip Code
02215
Giovannone, Barbara; Tsiaras, William G; de la Monte, Suzanne et al. (2009) GIGYF2 gene disruption in mice results in neurodegeneration and altered insulin-like growth factor signaling. Hum Mol Genet 18:4629-39
Lautier, Corinne; Goldwurm, Stefano; Durr, Alexandra et al. (2008) Mutations in the GIGYF2 (TNRC15) gene at the PARK11 locus in familial Parkinson disease. Am J Hum Genet 82:822-33
Ling, Pei-Ra; Smith, Robert J; Bistrian, Bruce R (2007) Acute effects of hyperglycemia and hyperinsulinemia on hepatic oxidative stress and the systemic inflammatory response in rats. Crit Care Med 35:555-60
Dufresne, Aimee M; Smith, Robert J (2005) The adapter protein GRB10 is an endogenous negative regulator of insulin-like growth factor signaling. Endocrinology 146:4399-409
Mori, Katsuhito; Giovannone, Barbara; Smith, Robert J (2005) Distinct Grb10 domain requirements for effects on glucose uptake and insulin signaling. Mol Cell Endocrinol 230:39-50
Ling, Pei-Ra; Smith, Robert J; Kie, Susanne et al. (2004) Effects of protein malnutrition on IL-6-mediated signaling in the liver and the systemic acute-phase response in rats. Am J Physiol Regul Integr Comp Physiol 287:R801-8
Giovannone, Barbara; Lee, Eunhee; Laviola, Luigi et al. (2003) Two novel proteins that are linked to insulin-like growth factor (IGF-I) receptors by the Grb10 adapter and modulate IGF-I signaling. J Biol Chem 278:31564-73
Abuzzahab, M Jennifer; Schneider, Anke; Goddard, Audrey et al. (2003) IGF-I receptor mutations resulting in intrauterine and postnatal growth retardation. N Engl J Med 349:2211-22
McCowen, K C; Ling, P R; Ciccarone, A et al. (2001) Sustained endotoxemia leads to marked down-regulation of early steps in the insulin-signaling cascade. Crit Care Med 29:839-46
Wang, P H; Almahfouz, A; Giorgino, F et al. (1999) In vivo insulin signaling in the myocardium of streptozotocin-diabetic rats: opposite effects of diabetes on insulin stimulation of glycogen synthase and c-Fos. Endocrinology 140:1141-50

Showing the most recent 10 out of 24 publications